NeurATRIS/EATRIS neuroscience webinar series: ultra-high field MRI with FLI

After obtaining a Masters and Engineer Diploma in Signal and Image Processing from the National Institute of Applied Sciences of Lyon, Cyril Poupon completed a PhD in Biomedical imaging at Telecom ParisTech and Frédéric Joliot Hospital Service (CEA, Orsay). His research was focused on the development of one of the first methods to map in vivo the structural connectivity of the human brain from diffusion-weighted MRI data, contributing to better understand the human brain connectome.

After a period of three years working for General Electric HealthCare (2000-2002) as a research engineer, Cyril Poupon was hired by the CEA in 2002 as a MR physicist and moved to Neurospin in 2007 where he successively held a position of MR physicist in the laboratory of MRI and Spectroscopy, and the position of Expert in Image Processing in the laboratory of Image Analysis.

In 2010, Cyril Poupon took the position of Director of the laboratory of MRI and Spectroscopy of Neurospin, co-leading the two following transverse research programs: “Pushing the limits of MRI” targeting the development with his team of ultra-high field imaging methods and “Multiscale Human Brain Architecture” modeling the human brain at various scales, and developing, in particular, methods to map the human brain structural connectome and tissue microstructure. Since 2017, he has become the Deputy Director of Neurospin in charge of the MRI platform.

Since 2018, Cyril Poupon is also Chairman of the EATRIS Imaging & Tracers Platform.

Fawzi Boumezbeur is a Physicist at NeuroSpin (Commissariat à l’Energie Atomique – CEA) specializing in Magnetic Resonance Spectroscopy (MRS) and non-proton (13C, 31P, 7Li, 23Na) Magnetic Resonance Imaging at ultra-high magnetic field. After a Bachelor degree in Engineering from the Ecole Supérieure de Physique et Chimie Industrielles (Paris) and a Master degree in Medical Imaging from University Paris-Sud (Orsay), Fawzi Boumezbeur did his PhD at Service Hospitalier Frédéric Joliot (Orsay) and spend two years as a post-doctoral fellow at Yale University (New Haven, CT, USA) studying normal and pathological energy metabolism and neurotransmission in the brain using in vivo 1H and 13C MRS. His research is focused on developing, validating and applying new MR biomarkers to investigate brain physiology, metabolism and pharmacology from animal models to patients cohorts.